- TestQuick diagnoses Staph infections in 30 mins or less... saving lives.
- The processTestQuick is the first "pre-culture" diagnostic platform for Staph
Step 1Patient fluids are added directly to our proprietary cassettes.• Blood
• Sputum
• Urine• Cerebrospinal Fluid
Step 2Our proprietary cassettes contain novel nanoparticles which detect bacterial proteins released into fluid reservoir in real-time.
Step 3In the presence of the bacterial proteins, the bulk properties of the nanoparticles are modulated.
Step 4In less than 30 minutes, the cassette is placed into the handheld reader for measurement, analysis, diagnosis and upload to hospital EMRs.
Step 5The appropriate therapeutic can be delivered by the doctor and the patient's hopsital EMR records are updated seamlessly.
- FoundersCharleson S. Bell, PhDPresident and Chief Executive OfficerCharleson is a PhD candidate at Vanderbilt University's biomedical engineering program. The culmination of Charleson’s previous studies in low analyte detection of cancer biomarkers and the fabrication of novel nanoparticles with his current studies regarding the treatment of multi-drug resistant bacteria, lead him to devise the technology behind BioNanovations’ diagnostic strategy.Todd Giorgio, PhDLead Scientific OfficerTodd is well suited due to his experience in the fields of development and application of nanotechnology to biology and medicine and his current appointment as Chair and Professor of Biomedical Engineering at Vanderbilt University and Chair of the Council of Chairs of the Biomedical Engineering Society. These appointments give him great breadth and reach as an internationally recognized center of scientific influence.
- Learn more aboutBioNanovations
Follow us!
Connect with us!
Like us!
Email us!
